These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 22585214)

  • 1. In vitro activity of TP-271 against Mycobacterium abscessus, Mycobacterium fortuitum, and Nocardia species.
    Cynamon M; Jureller J; Desai B; Ramachandran K; Sklaney M; Grossman TH
    Antimicrob Agents Chemother; 2012 Jul; 56(7):3986-8. PubMed ID: 22585214
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Shoen C; Benaroch D; Sklaney M; Cynamon M
    Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30858221
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Shen Y; Wang X; Jin J; Wu J; Zhang X; Chen J; Zhang W
    Biomed Res Int; 2018; 2018():4902941. PubMed ID: 30687747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility of rapidly growing mycobacteria and Nocardia isolates from cats and dogs to pradofloxacin.
    Govendir M; Norris JM; Hansen T; Wigney DI; Muscatello G; Trott DJ; Malik R
    Vet Microbiol; 2011 Dec; 153(3-4):240-5. PubMed ID: 21726965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High prevalence of antimicrobial resistance in rapidly growing mycobacteria in Taiwan.
    Yang SC; Hsueh PR; Lai HC; Teng LJ; Huang LM; Chen JM; Wang SK; Shie DC; Ho SW; Luh KT
    Antimicrob Agents Chemother; 2003 Jun; 47(6):1958-62. PubMed ID: 12760874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activities of linezolid against rapidly growing mycobacteria.
    Wallace RJ; Brown-Elliott BA; Ward SC; Crist CJ; Mann LB; Wilson RW
    Antimicrob Agents Chemother; 2001 Mar; 45(3):764-7. PubMed ID: 11181357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activities of the novel oxazolidinones DA-7867 and DA-7157 against rapidly and slowly growing mycobacteria.
    Vera-Cabrera L; Brown-Elliott BA; Wallace RJ; Ocampo-Candiani J; Welsh O; Choi SH; Molina-Torres CA
    Antimicrob Agents Chemother; 2006 Dec; 50(12):4027-9. PubMed ID: 17015632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activities of the glycylcyclines N,N-dimethylglycylamido-minocycline and N,N-dimethylglycylamido-6-demethyl-6-deoxytetracycline against Nocardia spp. and tetracycline-resistant isolates of rapidly growing mycobacteria.
    Brown BA; Wallace RJ; Onyi G
    Antimicrob Agents Chemother; 1996 Apr; 40(4):874-8. PubMed ID: 8849243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multisite reproducibility of results obtained by the broth microdilution method for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum.
    Woods GL; Bergmann JS; Witebsky FG; Fahle GA; Wanger A; Boulet B; Plaunt M; Brown BA; Wallace RJ
    J Clin Microbiol; 1999 Jun; 37(6):1676-82. PubMed ID: 10325306
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Zhang T; Du J; Dong L; Wang F; Zhao L; Jia J; Wang C; Cheng M; Yu X; Huang H
    Microbiol Spectr; 2023 Feb; 11(1):e0323822. PubMed ID: 36475850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High efficacy of clofazimine and its synergistic effect with amikacin against rapidly growing mycobacteria.
    Shen GH; Wu BD; Hu ST; Lin CF; Wu KM; Chen JH
    Int J Antimicrob Agents; 2010 Apr; 35(4):400-4. PubMed ID: 20138481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multisite reproducibility of Etest for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum.
    Woods GL; Bergmann JS; Witebsky FG; Fahle GA; Boulet B; Plaunt M; Brown BA; Wallace RJ; Wanger A
    J Clin Microbiol; 2000 Feb; 38(2):656-61. PubMed ID: 10655363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Species Distribution and Macrolide Susceptibility of
    Kim SY; Moon SM; Jhun BW; Kwon OJ; Huh HJ; Lee NY; Lee SH; Shin SJ; Kasperbauer SH; Huitt GA; Daley CL; Koh WJ
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30885902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the in vitro activity of the glycylcycline tigecycline (formerly GAR-936) with those of tetracycline, minocycline, and doxycycline against isolates of nontuberculous mycobacteria.
    Wallace RJ; Brown-Elliott BA; Crist CJ; Mann L; Wilson RW
    Antimicrob Agents Chemother; 2002 Oct; 46(10):3164-7. PubMed ID: 12234839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vitro activities of isepamicin, other aminoglycosides, and capreomycin against clinical isolates of rapidly growing mycobacteria in Taiwan.
    Shen GH; Wu BD; Wu KM; Chen JH
    Antimicrob Agents Chemother; 2007 May; 51(5):1849-51. PubMed ID: 17353252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial susceptibility testing of Mycobacteroides (Mycobacterium) abscessus complex, Mycolicibacterium (Mycobacterium) fortuitum, and Mycobacteroides (Mycobacterium) chelonae.
    Aono A; Morimoto K; Chikamatsu K; Yamada H; Igarashi Y; Murase Y; Takaki A; Mitarai S
    J Infect Chemother; 2019 Feb; 25(2):117-123. PubMed ID: 30447882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of PBTZ169 and pretomanid against Mycobacterium avium,
    Zheng L; Qi X; Zhang W; Wang H; Fu L; Wang B; Chen X; Chen X; Lu Y
    Front Cell Infect Microbiol; 2023; 13():1115530. PubMed ID: 37077530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Susceptibility to antimicrobial agents of rapidly growing mycobacteria].
    Ruiz-Aragón J; García-Agudo L; Flores S; Rodríguez MJ; Marín P; García-Martos P
    Rev Esp Quimioter; 2007 Dec; 20(4):429-32. PubMed ID: 18563216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Vitro Comparison of Ertapenem, Meropenem, and Imipenem against Isolates of Rapidly Growing Mycobacteria and Nocardia by Use of Broth Microdilution and Etest.
    Brown-Elliott BA; Killingley J; Vasireddy S; Bridge L; Wallace RJ
    J Clin Microbiol; 2016 Jun; 54(6):1586-1592. PubMed ID: 27053677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of various drugs alone or in combination against Mycobacterium fortuitum.
    Santos A; Cremades R; Rodríguez JC; Garcia-Pachon E; Ruiz M; Royo G
    J Infect Chemother; 2010 Feb; 16(1):64-7. PubMed ID: 20063030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.